Pramipexole, a dopamine agonist, in major depression: Antidepressant effects and tolerability in an open-label study with multiple doses

Clinical Neuropharmacology

Volumn 20, Issue SUPPL. 1, 1997, Pages

  Szegedi, Armin ^a   Hillert, Andreas ^a   Wetzel, Hermann ^a   Klieser, Eckard ^b   Gaebel, Wolfgang ^b   Benkert, Otto ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Depression; Dopamine; Pramipexole

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; RESTLESSNESS; TREATMENT OUTCOME;

EID: 0031407188     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199720001-00006     Document Type: Conference Paper

References (15)

1. 4 receptors. Eur J Pharmacol 1995;290:29-36.
2. Mierau J. Pramipexole: a dopamine-receptor agonist for treatment of Parkinson's disease. Clin Neuropharmacol 1995;18(suppl 1):S195-206.
3. Mann JJ, Kapur S. A dopaminergic hypothesis of major depression. Clin Neuropharmacol 1995;18(suppl 1):S57-65.
4. Schatzberg AF, Posener JA, Rothschild AJ. The role of dopamine in psychotic depression. Clin Neuropharmacol 1995;18(suppl 1):S66-73.
5. Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995;921-32.
6. Willner P, Scheel-Kruger J, eds. The mesolimbic dopamine system: from motivation to action. Chichester, UK: John Wiley, 1991.
7. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-54.
8. Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988;45:129-37.
9. Brown AS, Gershon S. Dopamine and depression. J Neural Transm [Gen Sect] 1993;91:75-109.
10. Waehrens J, Gerlach J. Bromocriptine and imipramine in endogenous depression. J Affect Disord 1981;3:193-202.
11. Theohar C, Fischer-Cornelssen K, Akesson HO, et al. Bromocriptine as antidepressant: double-blind comparative study with imipramine in psychogenic and endogenous depression. Curr Ther Res 1981;30:830-42.
12. Benkert O, Holsboer F. Effect of sulpiride in endogenous depression. Acta Psychiatr Scand 1984;69(suppl 311):43-8.
13. Bouckoms A, Mangini L. Pergolide: an antidepressant adjuvant for mood disorders? Psychopharmacol Bull 1993;29:207-11.
14. Gründer G, Wetzel H, Hammes E, Benkert O. Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression. Psychopharmacology 1993;111:123-6.
15. Benkert O, Gründer G, Wetzel H. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry 1992;25:254-60.